Summarized by Masters of Longevity from Longevity Technology.
Preclinical data show one injection durably lowered LDL in non-human primates.
Key Takeaways
- A single CRISPR injection lowered LDL cholesterol for two years.
- Scribe's CRISPR targets liver lipid genes including PCSK9 and LPA.
- Findings were preclinical and do not establish human efficacy.
